We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

National Survey on Asthma (SYMPTOMES)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00770250
First Posted: October 9, 2008
Last Update Posted: December 2, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
October 7, 2008
October 9, 2008
December 2, 2010
September 2008
Not Provided
The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control. [ Time Frame: Once ]
Same as current
Complete list of historical versions of study NCT00770250 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
National Survey on Asthma
A Mirror Assessment of the Words Used By Patients and Physicians to Express Asthma Symptoms, According To the Patient's Level of Asthma Control In General Medicine
To evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Probability Sample
The first 2 consecutive patients seen during the GP's visit with a diagnosis of persistent asthma
Asthma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1704
March 2009
Not Provided

Inclusion Criteria:

  • A diagnosis of persistent asthma treated with an inhaled corticosteroid based maintenance treatment for more than 3 months
  • Given his/her consent to participate to the study and who is able to answer the questionnaire in french by him/her-self.

Exclusion Criteria:

  • Patient with a cardiac disease (congestive heart failure, coronary artery disease)
  • Patient with a respiratory disease other than asthma (COPD, sleep apnea syndrome).
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT00770250
NIS-RFR-DUM-2008/1
No
Not Provided
Not Provided
Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals
AstraZeneca
Not Provided
Study Director: Alain Castaigne AstraZeneca
AstraZeneca
November 2010